Serve as the toxicology subject matter expert on cross-functional discovery and development teams and provide strategic nonclinical safety recommendations to support program progression and development decision-making
Lead and oversee IND and NDA enabling GLP toxicology studies
Review, analyze and interpret scientific data and results for toxicology studies and integrate findings into overall nonclinical safety assessments and development strategies
Manage outsourcing and study activities, study timelines, budgets, and deliverables for assigned programs
Communicate toxicology findings and risk assessments to project teams and senior leadership, influencing program decisions through scientifically sound and risk-based recommendations
Act as author/co-author and reviewer of regulatory documents
Collaborate within the nonclinical team to incorporate new guidance requirements
Analyze competitive scientific knowledge from external sources
Contribute to continuous improvement initiatives, scientific standards, and implementation of evolving regulatory guidance within Nonclinical Drug Safety
Requirements
MSc or PhD in Toxicology, Pharmacology or related areas with at least 7 years of experience in a pharmaceutical company or contract research organization
Diplomate of the American Board of Toxicology (DABT) is highly desired.
Strong preference to experience in Biologics
Strong technical experience in planning and executing nonclinical studies
Thorough knowledge of regulatory requirements and the overall drug development process
Regulatory expertise preferred, including successful IND/CTA submissions
Ability to switch tasks and priorities as business needs change and manage multiple programs simultaneously
Detail-oriented with strong written and verbal communication skills